Intensified Tuberculosis Case Finding Among HIV-infected Persons Using a WHO Symptom Screen and Xpert(®) MTB/RIF

Overview

Journal Int J Tuberc Lung Dis

Specialty Pulmonary Medicine

Date 2015 Oct 14

PMID 26459533

Citations 18

Authors

M W Adelman

M Tsegaye

R R Kempker

T Alebachew

K Haile

A Tesfaye

A Aseffa

H M Blumberg

Affiliations

Soon will be listed here.

Abstract

Setting: Human immunodeficiency virus (HIV) clinic in Addis Ababa, Ethiopia. The World Health Organization (WHO) recommends active tuberculosis (TB) case-finding among people living with HIV (PLHIV) in high-burden settings.

Objective: To evaluate the effectiveness of combining a WHO-recommended symptom screen and the Xpert(®) MTB/RIF test to enhance TB case finding.

Design: In this cross-sectional study, PLHIV were screened for TB using a WHO-recommended symptom-based algorithm (cough, fever, night sweats, weight loss). Those with a positive symptom screen (⩾1 symptom) underwent diagnostic testing with smear microscopy, culture, and Xpert.

Results: Of 828 PLHIV (89% on antiretroviral therapy), 321 (39%) had a positive symptom screen. In multivariate analysis, an unscheduled clinic visit (aOR 3.78, 95%CI 2.69-5.32), CD4 count <100 cells/μl (aOR 2.62, 95%CI 1.23-5.59) and previous history of TB (aOR 1.62, 95%CI 1.12-2.31) were predictors of a positive symptom screen. Among those with a positive symptom screen, 6% had active pulmonary TB. Smear microscopy sensitivity for TB was poor (30%) compared to culture and Xpert.

Conclusions: A positive symptom screen was common among PLHIV, creating a substantial laboratory burden. Smear microscopy had poor sensitivity for active TB disease. Given the high rate of positive symptom screen, substantial additional resources are needed to implement intensified TB case finding among PLHIV in high-burden areas.

Citing Articles

Tuberculosis screening, isoniazid preventive therapy coverage and factors associated with active TB diagnosis among people living with HIV at public health facilities of central Ethiopia.

Aboma M, Abdisa B, Imana G, Taye K, Moti G, Fufa M PLoS One. 2025; 20(3):e0319676.

PMID: 40063565 PMC: 11892821. DOI: 10.1371/journal.pone.0319676.

Cost-effectiveness analysis of a prediction model for community-based screening of active tuberculosis.

Yang C, Shih Y, Ayles H, Godfrey-Faussett P, Claassens M, Lin H J Glob Health. 2024; 14:04226.

PMID: 39575610 PMC: 11586587. DOI: 10.7189/jogh.14.04226.

Contributions of GeneXpert to TB diagnosis in Myanmar.

Burger Z, Aung H, Seifert M, Mar T, Harris V, Colman R Int J Tuberc Lung Dis. 2022; 26(9):875-879.

PMID: 35996278 PMC: 9423018. DOI: 10.5588/ijtld.22.0009.

Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis.

Dhana A, Hamada Y, Kengne A, Kerkhoff A, Rangaka M, Kredo T Lancet Infect Dis. 2021; 22(4):507-518.

PMID: 34800394 PMC: 8942858. DOI: 10.1016/S1473-3099(21)00387-X.

Tuberculosis screening coverage and isoniazid preventive therapy among people living with HIV at Gambella Hospital, southwest Ethiopia: a retrospective study design.

Aboma M, Dida N J Int Med Res. 2021; 49(9):3000605211046133.

PMID: 34551613 PMC: 8485319. DOI: 10.1177/03000605211046133.

References

Shah S, Demissie M, Lambert L, Ahmed J, Leulseged S, Kebede T . Intensified tuberculosis case finding among HIV-Infected persons from a voluntary counseling and testing center in Addis Ababa, Ethiopia. J Acquir Immune Defic Syndr. 2009; 50(5):537-45. DOI: 10.1097/QAI.0b013e318196761c. View

Abebe G, Deribew A, Apers L, Abdissa A, Kiflie Y, Koole O . Evaluation of the 2007 WHO guideline to diagnose smear negative tuberculosis in an urban hospital in Ethiopia. BMC Infect Dis. 2013; 13:427. PMC: 3849989. DOI: 10.1186/1471-2334-13-427. View

Balcha T, Sturegard E, Winqvist N, Skogmar S, Reepalu A, Habtamu Jemal Z . Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture. PLoS One. 2014; 9(1):e85478. PMC: 3899028. DOI: 10.1371/journal.pone.0085478. View

Theron G, Zijenah L, Chanda D, Clowes P, Rachow A, Lesosky M . Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial. Lancet. 2013; 383(9915):424-35. DOI: 10.1016/S0140-6736(13)62073-5. View

Denegetu A, Dolamo B . Tuberculosis case finding and isoniazid preventive therapy among people living with HIV at public health facilities of Addis Ababa, Ethiopia: a cross-sectional facility based study. BMC Public Health. 2014; 14:52. PMC: 3913332. DOI: 10.1186/1471-2458-14-52. View

Madon T, Hofman K, Kupfer L, Glass R . Public health. Implementation science. Science. 2007; 318(5857):1728-9. DOI: 10.1126/science.1150009. View

Fenner L, Ballif M, Graber C, Nhandu V, Dusingize J, Cortes C . Tuberculosis in antiretroviral treatment programs in lower income countries: availability and use of diagnostics and screening. PLoS One. 2013; 8(10):e77697. PMC: 3798412. DOI: 10.1371/journal.pone.0077697. View

Getahun H, Harrington M, OBrien R, Nunn P . Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet. 2007; 369(9578):2042-2049. DOI: 10.1016/S0140-6736(07)60284-0. View

Khan F, Verkuijl S, Parrish A, Chikwava F, Ntumy R, El-Sadr W . Performance of symptom-based tuberculosis screening among people living with HIV: not as great as hoped. AIDS. 2014; 28(10):1463-72. PMC: 5116236. DOI: 10.1097/QAD.0000000000000278. View

10.

Nakiyingi L, Bwanika J, Kirenga B, Nakanjako D, Katabira C, Lubega G . Clinical predictors and accuracy of empiric tuberculosis treatment among sputum smear-negative HIV-infected adult TB suspects in Uganda. PLoS One. 2013; 8(9):e74023. PMC: 3765314. DOI: 10.1371/journal.pone.0074023. View

11.

Saito S, Howard A, Reid M, Elul B, Scardigli A, Verkuijl S . TB diagnostic capacity in sub-Saharan African HIV care settings. J Acquir Immune Defic Syndr. 2012; 61(2):216-20. PMC: 3890234. DOI: 10.1097/QAI.0b013e3182638ec7. View

12.

Sculier D, Getahun H, Lienhardt C . Improving the prevention, diagnosis and treatment of TB among people living with HIV: the role of operational research. J Int AIDS Soc. 2011; 14 Suppl 1:S5. PMC: 3194150. DOI: 10.1186/1758-2652-14-S1-S5. View

13.

Lawn S, Nicol M . Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol. 2011; 6(9):1067-82. PMC: 3252681. DOI: 10.2217/fmb.11.84. View

14.

Lawn S, Brooks S, Kranzer K, Nicol M, Whitelaw A, Vogt M . Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study. PLoS Med. 2011; 8(7):e1001067. PMC: 3144215. DOI: 10.1371/journal.pmed.1001067. View

15.

Getahun H, Kittikraisak W, Heilig C, Corbett E, Ayles H, Cain K . Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Med. 2011; 8(1):e1000391. PMC: 3022524. DOI: 10.1371/journal.pmed.1000391. View

16.

Monkongdee P, McCarthy K, Cain K, Tasaneeyapan T, Nguyen H, Nguyen T . Yield of acid-fast smear and mycobacterial culture for tuberculosis diagnosis in people with human immunodeficiency virus. Am J Respir Crit Care Med. 2009; 180(9):903-8. DOI: 10.1164/rccm.200905-0692OC. View

17.

Harris P, Taylor R, Thielke R, Payne J, Gonzalez N, Conde J . Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2008; 42(2):377-81. PMC: 2700030. DOI: 10.1016/j.jbi.2008.08.010. View